Olodaterol (as hydrochloride) (Striverdi® Respimat®)

All Wales Medicines Strategy Group (AWMSG)
Record ID 32015000588
English
Authors' recommendations: Olodaterol (as hydrochloride) (Striverdi® Respimat®) is recommended as an option for use within NHS Wales as a maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
Details
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Wales, United Kingdom
MeSH Terms
  • Bronchodilator Agents
  • Adrenergic beta-2 Receptor Agonists
  • Benzoxazines
  • Pulmonary Disease, Chronic Obstructive
Contact
Organisation Name: All Wales Medicines Strategy Group
Contact Address: All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name: AWTTC@wales.nhs.uk
Contact Email: AWTTC@wales.nhs.uk
Copyright: AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.